NGNE
NGNE
NASDAQ · Biotechnology

Neurogene Inc

$35.34
-0.29 (-0.81%)
As of Aug 14, 2:16 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -28.9% upside
Low Target $17.03
Average Target $25.14
High Target $37.02
Current Price $35.34
Current
$35.34
Target
$25.14
$17.03 $25.14 avg $37.02
Scenario Analysis
Bear Case
$17.03
-51.8%
Low target
Base Case
$25.14
-28.9%
Avg target
Bull Case
$37.02
+4.8%
High target
Risk/Reward
0.1x
Unfavorable
Price in Context
52-Week High
$43.66
-19.1% from high
52-Week Low
$15.93
+121.8% from low
Target vs 52W High
$25.14
-42.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%